Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Triple-negative breast cancer (TNBC) is aggressive and has limited treatment options. This study explored the clinical significance of androgen receptor (AR) expression and tumor-infiltrating lymphocytes (TILs) in predicting neoadjuvant chemotherapy (NAC) resistance in TNBC, hypothesizing that AR/TIL classification can identify NAC-resistant subgroups and improve the understanding of apocrine differentiation. Methods This retrospective study included 96 consecutive patients with TNBC treated with NAC. AR immunostaining was defined as positive if ≥ 1% of the tumor cell nuclei were stained and stromal TIL levels were assessed, with high levels defined as ≥ 50%. Apocrine differentiation was detected using an anti-15-PGDH antibody. Pathological response to NAC was also evaluated. Results Overall, 38% (n = 36) of the patients achieved pathological complete response (pCR). AR + /TIL low tumors had a significantly higher non-pCR rate (79%, 23 of 29 patients) and were resistant to NAC. Kaplan-Meier plots showed significant differences in overall survival (OS) and distant metastasis-free survival (DMFS) among the four AR/TIL subgroups (OS, P = 0.047; DMFS, P = 0.0053). All seven cases with some degree of apocrine differentiation were AR + /TIL low , 15-PGDH-positive, and showed NAC resistance. AR + /TIL low status as an independent predictor of non-pCR (OR 0.32, P = 0.032). pCR predicted better prognosis (OS, HR 0.14, P = 0.010; DMFS, HR 0.11, P = 0.003), whereas AR + /TIL low status was not significantly associated with OS or DMFS. Conclusions AR/TIL classification was used to identify TNBC subgroups with distinct NAC responses and prognoses. AR + /TIL low TNBC, including cases with some degree of apocrine differentiation, are NAC-resistant, suggesting the need for alternative therapies.

Article activity feed